BrainStorm Cell Therapeutics

FDA calls out Brainstorm’s ALS stem cell therapy, says data don’t show benefit
FDA calls out Brainstorm’s ALS stem cell therapy, says data don’t show benefit
MedCity News
BrainStorm Cell Therapeutics
ALS
stem cell therapy
clinical trials
FDA
Flag link:
Despite red flag from FDA, controversial ALS cell therapy developer says it may still march ahead anyway
Despite red flag from FDA, controversial ALS cell therapy developer says it may still march ahead anyway
Endpoints
BrainStorm Cell Therapeutics
ALS
cell therapy
FDA
Flag link:
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
BrainStorm Cell Therapeutics
Allergan
Pfizer
Clovis Oncology
Acorda Therapeutics
Takeda
Agios Pharmaceuticals
Shire
Teva Pharmaceutical
AbbVie
Flag link:
ALS drug maker walks back plan to profit from right-to-try law following heavy criticism
ALS drug maker walks back plan to profit from right-to-try law following heavy criticism
Stat
BrainStorm Cell Therapeutics
right-to-try laws
ALS
clinical trials
NurOwn
Flag link:
Step right up: A biotech may soon sell an experimental med to dying ALS patients under ‘Right to Try’
Step right up: A biotech may soon sell an experimental med to dying ALS patients under ‘Right to Try’
Endpoints
right-to-try laws
ALS
BrainStorm Cell Therapeutics
Flag link:
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
TheStreet.com
BrainStorm Cell Therapeutics
stem cells
clinical trials
ALS
NurOwn
Flag link:
Israel's BrainStorm says stem cell drug benefits most patients in ALS trial
Israel's BrainStorm says stem cell drug benefits most patients in ALS trial
Reuters
BrainStorm Cell Therapeutics
stem cells
ALS
Lou Gehrig's disease
NurOwn
Flag link:
Brainstorm Cell Therapeutics Hits One-Year High Today
Brainstorm Cell Therapeutics Hits One-Year High Today
TheStreet.com
BrainStorm Cell Therapeutics
stem cells
NurOwn
ALS
Lou Gehrig's disease
Flag link:
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy
TheStreet.com
BrainStorm Cell Therapeutics
ALS
Flag link:
BrainStorm gets FDA fast-track status for ALS stem cell therapy
BrainStorm gets FDA fast-track status for ALS stem cell therapy
Yahoo/Reuters
BrainStorm Cell Therapeutics
FDA
ALS
stem cells
Flag link:
BrainStorm Receives Notice of Allowance on US Patent
BrainStorm Receives Notice of Allowance on US Patent
Yahoo
BrainStorm Cell Therapeutics
patents
stem cells
BDNF
brain-derived neurotrophic factor
Flag link:
BrainStorm Cell, Octane construct bioreactor prototype for NurOwn
BrainStorm Cell, Octane construct bioreactor prototype for NurOwn
Yahoo/Fly on the Wall
BrainStorm Cell Therapeutics
Octane Biotech
NurOwn
stem cells
Flag link:
BrainStorm Expands Pipeline With Initiation of Pre-Clinical Study in Autism
BrainStorm Expands Pipeline With Initiation of Pre-Clinical Study in Autism
Yahoo
BrainStorm Cell Therapeutics
autism
stem cells
Flag link:
FDA okays start of BrainStorm stem cell trial in ALS patients
FDA okays start of BrainStorm stem cell trial in ALS patients
Yahoo/Reuters
FDA
stem cells
ALS
clinical trials
BrainStorm Cell Therapeutics
Flag link:
Israel's BrainStorm gets U.S. patent for stem cell technology
Israel's BrainStorm gets U.S. patent for stem cell technology
Yahoo/Reuters
stem cells
BrainStorm Cell Therapeutics
Israel
patents
Flag link:
BrainStorm Cell Therapeutics says stem cells helped patient with ALS and MG
BrainStorm Cell Therapeutics says stem cells helped patient with ALS and MG
Reuters
ALS
BrainStorm Cell Therapeutics
stem cells
myasthenia gravis
Flag link:
Biotech: A Scattershot Of Stem Cell Plays Following Yesterday's Bloodbath
Biotech: A Scattershot Of Stem Cell Plays Following Yesterday's Bloodbath
Seeking Alpha
stem cells
StemCells
Pluristem
BioTime
BrainStorm Cell Therapeutics
Neuralstem
Flag link:
BrainStorm Submits Favorable Interim Safety Report for Second Group of Patients in Its Phase IIa Dose-Escalating Trial of NurOwn in ALS
BrainStorm Submits Favorable Interim Safety Report for Second Group of Patients in Its Phase IIa Dose-Escalating Trial of NurOwn in ALS
Yahoo/MarketWire
BrainStorm Cell Therapeutics
Lou Gehrig's disease
ALS
stem cells
NurOwn
Flag link:
Investing In The Stem Cell Sector: An Overview
Investing In The Stem Cell Sector: An Overview
Seeking Alpha
stem cells
Advanced Cell Technology
Aastrom Biosciences
BrainStorm Cell Therapeutics
Cytomedix
Neuralstem
Cytori
Fibrocell Science
International Stem Cell Corp
NeoStem
InVivo
Osiris
Pleuristem
RegenoCell
StemCells
Athersys
Flag link:
BrainStorm Cell reports outstanding ALS interim clinical trial results
BrainStorm Cell reports outstanding ALS interim clinical trial results
The Fly on the Wall
BrainStorm Cell Therapeutics
ALS
NurOwn
Flag link:

Pages